HIF1A and ovarian carcinoma: The HIF-1α signaling pathway promotes ovarian cancer growth through the augmentation of angiogenesis, metabolic reprogramming, epithelial–mesenchymal transition (EMT), chemoresistance, and immune evasion (Figure 2) [17].